MicroRNAs (miRNAs), one type of noncoding RNA, modulate post-transcriptional gene expression in various pathogenic pathways in type 2 diabetes (T2D). Currently, little is known about how miRNAs influence disease pathogenesis by targeting cells at a distance. The purpose of this study was to investigate the role of exosomal miRNAs during T2D.
Results:
We show that miR-15a is increased in the plasma of diabetic patients, correlating with disease severity. miR-15 plays an important role in insulin production in pancreatic β-cells. By culturing rat pancreatic β-cells (INS-1) cells in high-glucose media, we identified a source of increased miR-15a in the blood as exosomes secreted by pancreatic β-cells. We postulate that miR-15a, produced in pancreatic β-cells, can enter the bloodstream and contribute to retinal injury. miR-15a overexpression in Müller cells can be induced by exposing Müller cells to exosomes derived from INS-1 cells under high-glucose conditions and results in oxidative stress by targeting Akt3, which leads to apoptotic cell death. The in vivo relevance of these findings is supported by results from high-fat diet and pancreatic β-cell-specific miR-15a−/− mice.
Innovation:
This study highlights an important and underappreciated mechanism of remote cell–cell communication (exosomal transfer of miRNA) and its influence on the development of T2D complications.
Conclusion:
Our findings suggest that circulating miR-15a contributes to the pathogenesis of diabetes and supports the concept that miRNAs released by one cell type can travel through the circulation and play a role in disease progression via their transfer to different cell types, inducing oxidative stress and cell injury. Antioxid. Redox Signal. 27, 913–930.
Get full access to this article
View all access options for this article.
References
1.
AlexanderM, HuR, RuntschMC, KageleDA, MosbrugerTL, TolmachovaT, SeabraMC, RoundJL, WardDM, and O'ConnellRM. Exosome-delivered microRNAs modulate the inflammatory response to endotoxin. Nat Commun, 6: 7321, 2015.
2.
AndersonRE, RappLM, and WiegandRD. Lipid peroxidation and retinal degeneration. Curr Eye Res, 3: 223–227, 1984.
3.
BalasubramanyamM, AravindS, GokulakrishnanK, PrabuP, SathishkumarC, RanjaniH, and MohanV. Impaired miR-146a expression links subclinical inflammation and insulin resistance in type 2 diabetes. Mol Cell Biochem, 351: 197–205, 2011.
4.
BarileL, MoccettiT, MarbanE, and VassalliG. Roles of exosomes in cardioprotection. Eur Heart J pii: ehw304, 2016.
5.
CastilhoAF, LiberalJT, BaptistaFI, GasparJM, CarvalhoAL, and AmbrosioAF. Diabetes causes transient changes in the composition and phosphorylation of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors and interaction with auxiliary proteins in the rat retina. Mol Vis, 20: 894–907, 2014.
6.
ChaturvediP, KalaniA, MedinaI, FamiltsevaA, and TyagiSC. Cardiosome mediated regulation of MMP9 in diabetic heart: Role of mir29b and mir455 in exercise. J Cell Mol Med, 19: 2153–2161, 2015.
7.
ChavaliV, TyagiSC, and MishraPK. MicroRNA-133a regulates DNA methylation in diabetic cardiomyocytes. Biochem Biophys Res Commun, 425: 668–672, 2012.
8.
CimminoA, CalinGA, FabbriM, IorioMV, FerracinM, ShimizuM, WojcikSE, AqeilanRI, ZupoS, DonoM, RassentiL, AlderH, VoliniaS, LiuCG, KippsTJ, NegriniM, and CroceCM. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A, 102: 13944–13949, 2005.
9.
DasS, BedjaD, CampbellN, DunkerlyB, ChennaV, MaitraA, and SteenbergenC. miR-181c regulates the mitochondrial genome, bioenergetics, and propensity for heart failure in vivo. PLoS One, 9: e96820, 2014.
10.
DasS and HalushkaMK. Extracellular vesicle microRNA transfer in cardiovascular disease. Cardiovasc Pathol, 24: 199–206, 2015.
11.
DharA, DharI, DesaiKM, and WuL. Methylglyoxal scavengers attenuate endothelial dysfunction induced by methylglyoxal and high concentrations of glucose. Br J Pharmacol, 161: 1843–1856, 2010.
12.
ErenerS, MojibianM, FoxJK, DenrocheHC, and KiefferTJ. Circulating miR-375 as a biomarker of beta-cell death and diabetes in mice. Endocrinology, 154: 603–608, 2013.
13.
FengB, ChenS, GeorgeB, FengQ, and ChakrabartiS. miR133a regulates cardiomyocyte hypertrophy in diabetes. Diabetes Metab Res Rev, 26: 40–49, 2010.
14.
FiliosSR and ShalevA. β-cell microRNAs: Small but powerful. Diabetes, 64: 3631–3644, 2015.
15.
GourlayJ, MorokoffAP, LuworRB, ZhuHJ, KayeAH, and StylliSS. The emergent role of exosomes in glioma. J Clin Neurosci, 35: 13–23, 2016.
16.
GuayC, MenoudV, RomeS, and RegazziR. Horizontal transfer of exosomal microRNAs transduce apoptotic signals between pancreatic beta-cells. Cell Commun Signal, 13: 17, 2015.
17.
HaiderBA, BarasAS, McCallMN, HertelJA, CornishTC, and HalushkaMK. A critical evaluation of microRNA biomarkers in non-neoplastic disease. PLoS One, 9: e89565, 2014.
18.
HirotaK, KeinoH, InoueM, IshidaH, and HirakataA. Comparisons of microRNA expression profiles in vitreous humor between eyes with macular hole and eyes with proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol, 253: 335–342, 2015.
19.
HullingerTG, MontgomeryRL, SetoAG, DickinsonBA, SemusHM, LynchJM, DalbyCM, RobinsonK, StackC, LatimerPA, HareJM, OlsonEN, and van RooijE. Inhibition of miR-15 protects against cardiac ischemic injury. Circ Res, 110: 71–81, 2012.
20.
HurleyJH and OdorizziG. Get on the exosome bus with ALIX. Nat Cell Biol, 14: 654–655, 2012.
21.
JarryJ, SchadendorfD, GreenwoodC, SpatzA, and van KempenLC. The validity of circulating microRNAs in oncology: five years of challenges and contradictions. Mol Oncol, 8: 819–829, 2014.
22.
JoglekarMV, ParekhVS, MehtaS, BhondeRR, and HardikarAA. MicroRNA profiling of developing and regenerating pancreas reveal post-transcriptional regulation of neurogenin3. Dev Biol, 311: 603–612, 2007.
23.
JonesPF, JakubowiczT, PitossiFJ, MaurerF, and HemmingsBA. Molecular cloning and identification of a serine/threonine protein kinase of the second-messenger subfamily. Proc Natl Acad Sci U S A, 88: 4171–4175, 1991.
24.
KowluruRA and ChanPS. Oxidative stress and diabetic retinopathy. Exp Diabetes Res, 2007: 43603, 2007.
25.
KowluruRA and OdenbachS. Effect of long-term administration of alpha-lipoic acid on retinal capillary cell death and the development of retinopathy in diabetic rats. Diabetes, 53: 3233–3238, 2004.
26.
LatreilleM, HerrmannsK, RenwickN, TuschlT, MaleckiMT, McCarthyMI, OwenKR, RulickeT, and StoffelM. miR-375 gene dosage in pancreatic beta-cells: implications for regulation of beta-cell mass and biomarker development. J Mol Med (Berl), 93: 1159–1169, 2015.
27.
LinM, ChenY, JinJ, HuY, ZhouKK, ZhuM, LeYZ, GeJ, JohnsonRS, and MaJX. Ischaemia-induced retinal neovascularisation and diabetic retinopathy in mice with conditional knockout of hypoxia-inducible factor-1 in retinal Muller cells. Diabetologia, 54: 1554–1566, 2011.
28.
LynnFC, Skewes-CoxP, KosakaY, McManusMT, HarfeBD, and GermanMS. MicroRNA expression is required for pancreatic islet cell genesis in the mouse. Diabetes, 56: 2938–2945, 2007.
29.
Martinez-SanchezA, Nguyen-TuMS, and RutterGA. DICER inactivation identifies pancreatic beta-cell “disallowed” genes targeted by microRNAs. Mol Endocrinol, 29: 1067–1079, 2015.
30.
MeloSA, SugimotoH, O'ConnellJT, KatoN, VillanuevaA, VidalA, QiuL, VitkinE, PerelmanLT, MeloCA, LucciA, IvanC, CalinGA, and KalluriR. Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis. Cancer Cell, 26: 707–721, 2014.
31.
MitchellPS, ParkinRK, KrohEM, FritzBR, WymanSK, Pogosova-AgadjanyanEL, PetersonA, NoteboomJ, O'BriantKC, AllenA, LinDW, UrbanN, DrescherCW, KnudsenBS, StirewaltDL, GentlemanR, VessellaRL, NelsonPS, MartinDB, and TewariM. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A, 105: 10513–10518, 2008.
32.
MizutaniM, KernTS, and LorenziM. Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. J Clin Invest, 97: 2883–2890, 1996.
33.
MurphyE and SteenbergenC. Preconditioning: the mitochondrial connection. Annu Rev Physiol, 69: 51–67, 2007.
34.
MurphyE and SteenbergenC. Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol Rev, 88: 581–609, 2008.
35.
OsmaiM, OsmaiY, Bang-BerthelsenCH, PallesenEM, VestergaardAL, NovotnyGW, PociotF, and Mandrup-PoulsenT. microRNAs as regulators of beta-cell function and dysfunction. Diabetes Metab Res Rev, 32: 334–349, 2015.
PrentkiM and NolanCJ. Islet beta cell failure in type 2 diabetes. J Clin Invest, 116: 1802–1812, 2006.
38.
PritchardCC, KrohE, WoodB, ArroyoJD, DoughertyKJ, MiyajiMM, TaitJF, and TewariM. Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies. Cancer Prev Res (Phila), 5: 492–497, 2012.
39.
ReiterCE, SandirasegaraneL, WolpertEB, KlingerM, SimpsonIA, BarberAJ, AntonettiDA, KesterM, and GardnerTW. Characterization of insulin signaling in rat retina in vivo and ex vivo. Am J Physiol Endocrinol Metab, 285: E763–E774, 2003.
40.
SantosJM, MohammadG, ZhongQ, and KowluruRA. Diabetic retinopathy, superoxide damage and antioxidants. Curr Pharm Biotechnol, 12: 352–361, 2011.
41.
SebastianiG, GriecoFA, SpagnuoloI, GalleriL, CataldoD, and DottaF. Increased expression of microRNA miR-326 in type 1 diabetic patients with ongoing islet autoimmunity. Diabetes Metab Res Rev, 27: 862–866, 2011.
42.
ShantikumarS, AngeliniGD, and EmanueliC. Diabetes, microRNAs and exosomes: Les liaisons dangereuses. J Mol Cell Cardiol, 74: 196–198, 2014.
43.
SpinettiG, FortunatoO, CaporaliA, ShantikumarS, MarchettiM, MeloniM, DescampsB, FlorisI, SangalliE, VonoR, FagliaE, SpecchiaC, PintusG, MadedduP, and EmanueliC. MicroRNA-15a and microRNA-16 impair human circulating proangiogenic cell functions and are increased in the proangiogenic cells and serum of patients with critical limb ischemia. Circ Res, 112: 335–346, 2013.
44.
SunLL, JiangBG, LiWT, ZouJJ, ShiYQ, and LiuZM. MicroRNA-15a positively regulates insulin synthesis by inhibiting uncoupling protein-2 expression. Diabetes Res Clin Pract, 91: 94–100, 2011.
45.
TurchinovichA, WeizL, and BurwinkelB. Extracellular miRNAs: the mystery of their origin and function. Trends Biochem Sci, 37: 460–465, 2012.
46.
ValadiH, EkstromK, BossiosA, SjostrandM, LeeJJ, and LotvallJO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol, 9: 654–659, 2007.
47.
van de BuntM, GaultonKJ, PartsL, MoranI, JohnsonPR, LindgrenCM, FerrerJ, GloynAL, and McCarthyMI. The miRNA profile of human pancreatic islets and beta-cells and relationship to type 2 diabetes pathogenesis. PLoS One, 8: e55272, 2013.
48.
WangJ, XuX, ElliottMH, ZhuM, and LeYZ. Muller cell-derived VEGF is essential for diabetes-induced retinal inflammation and vascular leakage. Diabetes, 59: 2297–2305, 2010.
49.
XuZ, GongJ, MaitiD, VongL, WuL, SchwarzJJ, and DuhEJ. MEF2C ablation in endothelial cells reduces retinal vessel loss and suppresses pathologic retinal neovascularization in oxygen-induced retinopathy. Am J Pathol, 180: 2548–2560, 2012.
50.
XuZ, WeiY, GongJ, ChoH, ParkJK, SungER, HuangH, WuL, EberhartC, HandaJT, DuY, KernTS, ThimmulappaR, BarberAJ, BiswalS, and DuhEJ. NRF2 plays a protective role in diabetic retinopathy in mice. Diabetologia, 57: 204–213, 2014.
51.
ZampetakiA, KiechlS, DrozdovI, WilleitP, MayrU, ProkopiM, MayrA, WegerS, OberhollenzerF, BonoraE, ShahA, WilleitJ, and MayrM. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res, 107: 810–817, 2010.
52.
ZhangJ, LiS, LiL, LiM, GuoC, YaoJ, and MiS. Exosome and exosomal microRNA: trafficking, sorting, and function. Genomics Proteomics Bioinformatics, 13: 17–24, 2015.
53.
ZongH, WardM, MaddenA, YongPH, LimbGA, CurtisTM, and StittAW. Hyperglycaemia-induced pro-inflammatory responses by retinal Muller glia are regulated by the receptor for advanced glycation end-products (RAGE). Diabetologia, 53: 2656–2666, 2010.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
